Literature DB >> 19142168

Microscopic colitis associated with omeprazole and esomeprazole exposure.

Gilbert M Wilcox1, Anthony R Mattia.   

Abstract

GOALS: The aim of this study was to determine whether proton pump inhibitors other than lansoprazole might be associated with microscopic colitis.
BACKGROUND: Lansoprazole exposure has been associated with diarrhea and microscopic colitis, but this relationship has not been described with other proton pump inhibitors. STUDY: Cases of microscopic colitis from a consultative gastroenterology practice were collected and reviewed for proton pump inhibitor exposure. Standard clinical, endoscopic, and biopsy findings were analyzed.
RESULTS: A case series of 4 patients is described in which subjects developed classic symptoms of lymphocytic-collagenous colitis with typical mucosal histopathology during treatment with omeprazole/esomeprazole. Symptoms promptly stopped and mucosal biopsies returned to normal with drug withdrawal. Disease quickly recurred in 2 patients who were reexposed to the drugs, one with biopsy documented recurrent collagenous colitis.
CONCLUSIONS: Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure. These results have epidemiologic, diagnostic, and therapeutic ramifications, which are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142168     DOI: 10.1097/MCG.0b013e31817d3fa1

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

Review 1.  Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.

Authors:  Runjan Chetty; Dhirendra Govender
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Microscopic colitis and Medication Use.

Authors:  Monina F Pascua; Prashant Kedia; Mark G Weiner; John Holmes; Jonas Ellenberg; James D Lewis
Journal:  Clin Med Insights Gastroenterol       Date:  2010-05-18

3.  Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs.

Authors:  Gwen M C Masclee; Preciosa M Coloma; Ernst J Kuipers; Miriam C J M Sturkenboom
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

4.  Is use of PPIs related to increased intraepithelial lymphocytes in the colon?

Authors:  Yeon Hwa Yu; Dong Soo Han; Eun Young Choi; Hye Sun Park; Jae Yoon Jeong; Chang Soo Eun; Young Ha Oh; Ju Yeon Pyo
Journal:  Dig Dis Sci       Date:  2012-08-02       Impact factor: 3.199

Review 5.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

6.  Therapeutic effect of Streptococcus thermophilus CRL 1190-fermented milk on chronic gastritis.

Authors:  Cecilia Rodríguez; Marta Medici; Fernanda Mozzi; Graciela Font de Valdez
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

7.  Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China.

Authors:  Hong-Xiang Gu; Fa-Chao Zhi; Ying Huang; Ai-Min Li; Yang Bai; Bo Jiang; Ya-Li Zhang
Journal:  Int J Colorectal Dis       Date:  2012-03-21       Impact factor: 2.571

Review 8.  Proton-pump inhibitors: understanding the complications and risks.

Authors:  Peter Malfertheiner; Arne Kandulski; Marino Venerito
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

9.  Microscopic Colitis: A Review of Collagenous and Lymphocytic Colitis.

Authors:  Karen Boland; Geoffrey C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

10.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.